data_IMN
#
_chem_comp.id IMN
_chem_comp.name INDOMETHACIN
_chem_comp.type NON-POLYMER
_chem_comp.pdbx_type HETAIN
_chem_comp.formula "C19 H16 Cl N O4"
_chem_comp.mon_nstd_parent_comp_id ?
_chem_comp.pdbx_synonyms ?
_chem_comp.pdbx_formal_charge 0
_chem_comp.pdbx_initial_date 1999-07-08
_chem_comp.pdbx_modified_date 2011-06-04
_chem_comp.pdbx_ambiguous_flag N
_chem_comp.pdbx_release_status REL
_chem_comp.pdbx_replaced_by ?
_chem_comp.pdbx_replaces ?
_chem_comp.formula_weight 357.788
_chem_comp.one_letter_code ?
_chem_comp.three_letter_code IMN
_chem_comp.pdbx_model_coordinates_details ?
_chem_comp.pdbx_model_coordinates_missing_flag N
_chem_comp.pdbx_ideal_coordinates_details ?
_chem_comp.pdbx_ideal_coordinates_missing_flag N
_chem_comp.pdbx_model_coordinates_db_code 4COX
_chem_comp.pdbx_subcomponent_list ?
_chem_comp.pdbx_processing_site RCSB
#
loop_
_chem_comp_atom.comp_id
_chem_comp_atom.atom_id
_chem_comp_atom.alt_atom_id
_chem_comp_atom.type_symbol
_chem_comp_atom.charge
_chem_comp_atom.pdbx_align
_chem_comp_atom.pdbx_aromatic_flag
_chem_comp_atom.pdbx_leaving_atom_flag
_chem_comp_atom.pdbx_stereo_config
_chem_comp_atom.pdbx_backbone_atom_flag
_chem_comp_atom.pdbx_n_terminal_atom_flag
_chem_comp_atom.pdbx_c_terminal_atom_flag
_chem_comp_atom.model_Cartn_x
_chem_comp_atom.model_Cartn_y
_chem_comp_atom.model_Cartn_z
_chem_comp_atom.pdbx_model_Cartn_x_ideal
_chem_comp_atom.pdbx_model_Cartn_y_ideal
_chem_comp_atom.pdbx_model_Cartn_z_ideal
_chem_comp_atom.pdbx_component_atom_id
_chem_comp_atom.pdbx_component_comp_id
_chem_comp_atom.pdbx_ordinal
IMN C C C 0 1 Y N N N N N 60.214 43.705 74.033 0.797 0.741 1.060 C IMN 1
IMN C1 C1 C 0 1 Y N N N N N 60.167 44.692 75.051 0.149 0.305 2.229 C1 IMN 2
IMN C2 C2 C 0 1 Y N N N N N 61.370 45.200 75.611 0.884 -0.292 3.253 C2 IMN 3
IMN C3 C3 C 0 1 Y N N N N N 62.642 44.731 75.152 2.251 -0.441 3.114 C3 IMN 4
IMN C4 C4 C 0 1 Y N N N N N 62.704 43.719 74.114 2.889 -0.009 1.956 C4 IMN 5
IMN C5 C5 C 0 1 Y N N N N N 61.484 43.213 73.556 2.171 0.577 0.937 C5 IMN 6
IMN C6 C6 C 0 1 N N N N N N 65.098 44.712 75.330 4.335 -1.036 3.677 C6 IMN 7
IMN C7 C7 C 0 1 Y N N N N N 58.705 44.960 75.282 -1.272 0.617 2.048 C7 IMN 8
IMN C8 C8 C 0 1 Y N N N N N 58.020 44.170 74.448 -1.401 1.194 0.845 C8 IMN 9
IMN C9 C9 C 0 1 N N N N N N 58.435 42.451 72.857 0.051 1.807 -0.985 C9 IMN 10
IMN C10 C10 C 0 1 Y N N N N N 58.848 42.389 71.382 0.094 0.931 -2.173 C10 IMN 11
IMN C11 C11 C 0 1 Y N N N N N 58.673 41.182 70.661 0.433 1.458 -3.421 C11 IMN 12
IMN C12 C12 C 0 1 Y N N N N N 59.039 41.088 69.295 0.473 0.634 -4.526 C12 IMN 13
IMN C13 C13 C 0 1 Y N N N N N 59.564 42.162 68.654 0.177 -0.712 -4.400 C13 IMN 14
IMN C14 C14 C 0 1 Y N N N N N 59.751 43.348 69.337 -0.159 -1.241 -3.165 C14 IMN 15
IMN C15 C15 C 0 1 Y N N N N N 59.390 43.476 70.721 -0.196 -0.429 -2.051 C15 IMN 16
IMN C16 C16 C 0 1 N N N N N N 56.509 44.131 74.368 -2.699 1.677 0.250 C16 IMN 17
IMN C17 C17 C 0 1 N N N N N N 58.056 45.941 76.310 -2.381 0.341 3.030 C17 IMN 18
IMN C18 C18 C 0 1 N N N N N N 58.801 47.270 76.422 -2.956 -1.026 2.767 C18 IMN 19
IMN N N N 0 1 Y N N N N N 58.855 43.404 73.694 -0.173 1.279 0.233 N IMN 20
IMN O O O 0 1 N N N N N N 63.805 45.271 75.699 2.974 -1.018 4.111 O IMN 21
IMN O1 O1 O 0 1 N N N N N N 57.679 41.588 73.314 0.217 3.005 -1.107 O1 IMN 22
IMN O2 O2 O 0 1 N N N N N N 59.697 47.562 75.647 -2.512 -1.707 1.874 O2 IMN 23
IMN O3 O3 O 0 1 N N N N N N 58.474 48.117 77.354 -3.963 -1.488 3.526 O3 IMN 24
IMN CL CL CL 0 0 N N N N N N 59.924 42.053 66.997 0.229 -1.743 -5.796 CL IMN 25
IMN H2 H2 H 0 1 N N N N N N 61.316 45.962 76.406 0.389 -0.633 4.150 H2 IMN 26
IMN H4 H4 H 0 1 N N N N N N 63.672 43.336 73.751 3.957 -0.134 1.855 H4 IMN 27
IMN H5 H5 H 0 1 N N N N N N 61.522 42.447 72.762 2.676 0.910 0.042 H5 IMN 28
IMN H61 1H6 H 0 1 N N N N N N 66.028 45.143 75.767 4.957 -1.492 4.447 H61 IMN 29
IMN H62 2H6 H 0 1 N N N N N N 65.083 43.616 75.535 4.415 -1.614 2.756 H62 IMN 30
IMN H63 3H6 H 0 1 N N N N N N 65.187 44.726 74.218 4.672 -0.015 3.495 H63 IMN 31
IMN H11 H11 H 0 1 N N N N N N 58.245 40.302 71.170 0.664 2.508 -3.520 H11 IMN 32
IMN H12 H12 H 0 1 N N N N N N 58.912 40.157 68.717 0.734 1.041 -5.492 H12 IMN 33
IMN H14 H14 H 0 1 N N N N N N 60.188 44.192 68.777 -0.389 -2.292 -3.073 H14 IMN 34
IMN H15 H15 H 0 1 N N N N N N 59.530 44.416 71.280 -0.459 -0.842 -1.089 H15 IMN 35
IMN H161 1H16 H 0 0 N N N N N N 55.937 43.472 73.672 -3.160 0.870 -0.319 H161 IMN 36
IMN H162 2H16 H 0 0 N N N N N N 56.132 43.925 75.397 -3.371 1.987 1.050 H162 IMN 37
IMN H163 3H16 H 0 0 N N N N N N 56.164 45.175 74.186 -2.504 2.523 -0.408 H163 IMN 38
IMN H171 1H17 H 0 0 N N N N N N 56.978 46.107 76.075 -1.985 0.380 4.045 H171 IMN 39
IMN H172 2H17 H 0 0 N N N N N N 57.952 45.458 77.309 -3.163 1.092 2.916 H172 IMN 40
IMN HO3 HO3 H 0 1 N N N N N N 58.937 48.943 77.423 -4.332 -2.365 3.357 HO3 IMN 41
#
loop_
_chem_comp_bond.comp_id
_chem_comp_bond.atom_id_1
_chem_comp_bond.atom_id_2
_chem_comp_bond.value_order
_chem_comp_bond.pdbx_aromatic_flag
_chem_comp_bond.pdbx_stereo_config
_chem_comp_bond.pdbx_ordinal
IMN C C1 DOUB Y N 1
IMN C C5 SING Y N 2
IMN C N SING Y N 3
IMN C1 C2 SING Y N 4
IMN C1 C7 SING Y N 5
IMN C2 C3 DOUB Y N 6
IMN C2 H2 SING N N 7
IMN C3 C4 SING Y N 8
IMN C3 O SING N N 9
IMN C4 C5 DOUB Y N 10
IMN C4 H4 SING N N 11
IMN C5 H5 SING N N 12
IMN C6 O SING N N 13
IMN C6 H61 SING N N 14
IMN C6 H62 SING N N 15
IMN C6 H63 SING N N 16
IMN C7 C8 DOUB Y N 17
IMN C7 C17 SING N N 18
IMN C8 C16 SING N N 19
IMN C8 N SING Y N 20
IMN C9 C10 SING N N 21
IMN C9 N SING N N 22
IMN C9 O1 DOUB N N 23
IMN C10 C11 DOUB Y N 24
IMN C10 C15 SING Y N 25
IMN C11 C12 SING Y N 26
IMN C11 H11 SING N N 27
IMN C12 C13 DOUB Y N 28
IMN C12 H12 SING N N 29
IMN C13 C14 SING Y N 30
IMN C13 CL SING N N 31
IMN C14 C15 DOUB Y N 32
IMN C14 H14 SING N N 33
IMN C15 H15 SING N N 34
IMN C16 H161 SING N N 35
IMN C16 H162 SING N N 36
IMN C16 H163 SING N N 37
IMN C17 C18 SING N N 38
IMN C17 H171 SING N N 39
IMN C17 H172 SING N N 40
IMN C18 O2 DOUB N N 41
IMN C18 O3 SING N N 42
IMN O3 HO3 SING N N 43
#
loop_
_pdbx_chem_comp_descriptor.comp_id
_pdbx_chem_comp_descriptor.type
_pdbx_chem_comp_descriptor.program
_pdbx_chem_comp_descriptor.program_version
_pdbx_chem_comp_descriptor.descriptor
IMN SMILES ACDLabs 10.04 Clc1ccc(cc1)C(=O)n3c2ccc(OC)cc2c(c3C)CC(=O)O
IMN SMILES_CANONICAL CACTVS 3.341 COc1ccc2n(c(C)c(CC(O)=O)c2c1)C(=O)c3ccc(Cl)cc3
IMN SMILES CACTVS 3.341 COc1ccc2n(c(C)c(CC(O)=O)c2c1)C(=O)c3ccc(Cl)cc3
IMN SMILES_CANONICAL "OpenEye OEToolkits" 1.5.0 Cc1c(c2cc(ccc2n1C(=O)c3ccc(cc3)Cl)OC)CC(=O)O
IMN SMILES "OpenEye OEToolkits" 1.5.0 Cc1c(c2cc(ccc2n1C(=O)c3ccc(cc3)Cl)OC)CC(=O)O
IMN InChI InChI 1.03 InChI=1S/C19H16ClNO4/c1-11-15(10-18(22)23)16-9-14(25-2)7-8-17(16)21(11)19(24)12-3-5-13(20)6-4-12/h3-9H,10H2,1-2H3,(H,22,23)
IMN InChIKey InChI 1.03 CGIGDMFJXJATDK-UHFFFAOYSA-N
#
loop_
_pdbx_chem_comp_identifier.comp_id
_pdbx_chem_comp_identifier.type
_pdbx_chem_comp_identifier.program
_pdbx_chem_comp_identifier.program_version
_pdbx_chem_comp_identifier.identifier
IMN "SYSTEMATIC NAME" ACDLabs 10.04 "{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid"
IMN "SYSTEMATIC NAME" "OpenEye OEToolkits" 1.5.0 "2-[1-(4-chlorophenyl)carbonyl-5-methoxy-2-methyl-indol-3-yl]ethanoic acid"
#
loop_
_pdbx_chem_comp_audit.comp_id
_pdbx_chem_comp_audit.action_type
_pdbx_chem_comp_audit.date
_pdbx_chem_comp_audit.processing_site
IMN 'Create component' 1999-07-08 RCSB
IMN 'Modify descriptor' 2011-06-04 RCSB
#
_pdbe_chem_comp_drugbank_details.comp_id IMN
_pdbe_chem_comp_drugbank_details.drugbank_id DB00328
_pdbe_chem_comp_drugbank_details.type 'small molecule'
_pdbe_chem_comp_drugbank_details.name Indomethacin
_pdbe_chem_comp_drugbank_details.description
'Indometacin, or indomethacin, is a non-steroidal anti-inflammatory drug (NSAID) with anti-inflammatory, analgesic, and antipyretic properties. NSAIDs consist of agents that are structurally unrelated; the NSAID chemical classification of indometacin is an indole-acetic acid derivative with the chemical name 1- (p-chlorobenzoyl)25-methoxy-2-methylindole-3-acetic acid.[A177871] The pharmacological effect of indometacin is not fully understood, however, it is thought to be mediated through potent and nonselective inhibition of the enzyme cyclooxygenase (COX), which is the main enzyme responsible for catalyzes the rate-limiting step in prostaglandin and thromboxane biosynthesis via the arachidonic acid (AA) pathway. Indometacin was first discovered in 1963 and it was first approved for use in the U.S. by the Food and Drug Administration in 1965, [A486] along with other acetic acid derivatives such as [diclofenac] and [sulindac] that were also developed during the 1960s.[A177871] Since then, indometacin has been extensively studied in clinical trials as one of the most potent NSAIDs in blocking prostaglandin synthesis and was among the first NSAIDs to be used in the symptomatic treatment of migraine and for headaches that eventually became known as “indomethacin-responsive” headache disorders.[A177871]   Most commonly used in rheumatoid arthritis, ankylosing spondylitis, osteoarthritis, acute shoulder pains, and acute gouty arthritis, indometacin is currently available as oral capsules as well as other methods of administration, including rectal and intravenous formulations. Intravenous indometacin is administered to close a hemodynamically significant patent ductus arteriosus, as indicated by clinical evidence, in premature infants.[L10553] Ophthalmic indometacin has been studied and used in the symptomatic treatment of postoperative ocular inflammation and pain and/or complications after cataract surgery. Although deemed effective in reducing ocular inflammation in clinical studies, topical NSAIDs were also associated with a potential reduction in corneal sensitivity accompanied by an increased risk of superficial punctate keratitis and subjective symptoms of discomfort, including pain, burning or pricking, or a tingling sensation after instillation into the cul‐de‐sac.[A177949]'
_pdbe_chem_comp_drugbank_details.cas_number 53-86-1
_pdbe_chem_comp_drugbank_details.mechanism_of_action
"Indometacin is a nonspecific and reversible inhibitor of the cyclo-oxygenase (COX) enzyme or prostaglandin G/H synthase. There are two identified isoforms of COX: COX-1 is universally present in most body tissues and is involved in the synthesis of the prostaglandins and thromboxane A2, while COX-2 is expressed in response to injury or inflammation.[A177871] Constitutively expressed, the COX-1 enzyme is involved in gastric mucosal protection, platelet, and kidney function by catalyzing the conversion of arachidonic acid to prostaglandin (PG) G2 and PGG2 to PGH2.[A177871] COX-2 is constitutively expressed and highly inducible by inflammatory stimuli. It is found in the central nervous system, kidneys, uterus, and other organs. COX-2 also catalyzes the conversion of arachidonic acid to PGG2 and PGG2 to PGH2. In the COX-2-mediated pathway, PGH2 is further converted to PGE2 and PGI2 (also known as prostacyclin). PGE2 is involved in mediating inflammation, pain, and fever. Decreasing levels of PGE2 leads to reduced inflammatory reactions. Indometacin is known to inhibit both isoforms of COX, however, with greater selectivity for COX-1, which accounts for its increased adverse gastric effects relative to other NSAIDs. It binds to the enzyme's active site and prevents the interaction between the enzyme and its substrate, arachidonic acid. Indometacin, unlike other NSAIDs, also inhibits phospholipase A2, the enzyme responsible for releasing arachidonic acid from phospholipids. The analgesic, antipyretic and anti-inflammatory effects of indomethacin as well as adverse reactions associated with the drug occur as a result of decreased prostaglandin synthesis. Its antipyretic effects may be due to action on the hypothalamus, resulting in increased peripheral blood flow, vasodilation, and subsequent heat dissipation.  The exact mechanism of action of indometacin in inducing closure of a patent ductus arteriosus is not fully understood; however, it is thought to be through inhibition of prostaglandin synthesis.[L6778] At birth, the ductus arteriosus is normally closed as the tension of the oxygen increases significantly after birth.[A177880] Patent ductus arteriosus in premature infants is associated with congenital heart malformations where PGE1 mediates an opposite effect to that of oxygen. PGE1 dilates the ductus arteriosus through smooth muscle relaxation and prevents the closure of the ductus arteriosus.[A177880] By inhibiting the synthesis of prostaglandins, indometacin promotes the closure of ductus arteriosus.[L10553]  Indometacin has been described as possessing anticancer and antiviral properties through activation of protein kinase R (PKR) and downstream phosphorylation of eIF2α, inhibiting protein synthesis.[A234429, A234434]"
#
loop_
_pdbe_chem_comp_synonyms.comp_id
_pdbe_chem_comp_synonyms.name
_pdbe_chem_comp_synonyms.provenance
_pdbe_chem_comp_synonyms.type
IMN '{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid' DrugBank ?
IMN '1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid' DrugBank ?
IMN Indometacin DrugBank ?
IMN Indometacinum DrugBank ?
IMN Indomethacin DrugBank ?
IMN Aconip DrugBank 'International brand'
IMN Arthrexin DrugBank 'International brand'
IMN Elmetacin DrugBank 'International brand'
IMN Indaflex DrugBank 'International brand'
IMN Indocid DrugBank 'International brand'
IMN 'Indolar SR' DrugBank 'International brand'
IMN Indomed DrugBank 'International brand'
IMN Indoxen DrugBank 'International brand'
IMN Metindol DrugBank 'International brand'
IMN Mikametan DrugBank 'International brand'
IMN Nu-Indo DrugBank 'International brand'
IMN Reumacide DrugBank 'International brand'
#
_pdbe_chem_comp_drugbank_classification.comp_id IMN
_pdbe_chem_comp_drugbank_classification.drugbank_id DB00328
_pdbe_chem_comp_drugbank_classification.parent Benzoylindoles
_pdbe_chem_comp_drugbank_classification.kingdom 'Organic compounds'
_pdbe_chem_comp_drugbank_classification.class 'Indoles and derivatives'
_pdbe_chem_comp_drugbank_classification.superclass 'Organoheterocyclic compounds'
_pdbe_chem_comp_drugbank_classification.description
'This compound belongs to the class of organic compounds known as benzoylindoles. These are organic compounds containing an indole attached to a benzoyl moiety through the acyl group.'
#
loop_
_pdbe_chem_comp_drugbank_targets.comp_id
_pdbe_chem_comp_drugbank_targets.drugbank_id
_pdbe_chem_comp_drugbank_targets.name
_pdbe_chem_comp_drugbank_targets.organism
_pdbe_chem_comp_drugbank_targets.uniprot_id
_pdbe_chem_comp_drugbank_targets.pharmacologically_active
_pdbe_chem_comp_drugbank_targets.ordinal
IMN DB00328 'Prostaglandin G/H synthase 2' Humans P35354 yes 1
IMN DB00328 'Phospholipase A2, membrane associated' Humans P14555 yes 2
IMN DB00328 'Prostaglandin G/H synthase 1' Humans P23219 yes 3
IMN DB00328 'Prostaglandin G/H synthase 2' Humans P35354 yes 4
IMN DB00328 'Prostaglandin G/H synthase 1' Humans P23219 yes 5
IMN DB00328 'Interferon-induced, double-stranded RNA-activated protein kinase' Humans P19525 yes 6
IMN DB00328 'Prostaglandin reductase 2' Humans Q8N8N7 unknown 7
IMN DB00328 'Peroxisome proliferator-activated receptor gamma' Humans P37231 unknown 8
IMN DB00328 'Lactoylglutathione lyase' Humans Q04760 unknown 9
IMN DB00328 'Prostaglandin D2 receptor 2' Humans Q9Y5Y4 unknown 10
IMN DB00328 'Peroxisome proliferator-activated receptor alpha' Humans Q07869 unknown 11
IMN DB00328 'Aldo-keto reductase family 1 member C3' Humans P42330 unknown 12
#
loop_
_software.name
_software.version
_software.description
rdkit 2025.03.3 'Core functionality.'
pdbeccdutils 1.0.0 'Wrapper to provide 2D templates and molecular fragments.'
#
loop_
_pdbe_chem_comp_atom_depiction.comp_id
_pdbe_chem_comp_atom_depiction.atom_id
_pdbe_chem_comp_atom_depiction.element
_pdbe_chem_comp_atom_depiction.model_Cartn_x
_pdbe_chem_comp_atom_depiction.model_Cartn_y
_pdbe_chem_comp_atom_depiction.pdbx_ordinal
IMN C C 8.196 -1.345 1
IMN C1 C 8.196 0.155 2
IMN C2 C 6.897 0.905 3
IMN C3 C 5.598 0.155 4
IMN C4 C 5.598 -1.345 5
IMN C5 C 6.897 -2.095 6
IMN C6 C 3.000 0.155 7
IMN C7 C 9.616 0.612 8
IMN C8 C 10.491 -0.595 9
IMN C9 C 10.082 -3.228 10
IMN C10 C 11.549 -3.537 11
IMN C11 C 12.015 -4.963 12
IMN C12 C 13.483 -5.272 13
IMN C13 C 14.485 -4.156 14
IMN C14 C 14.019 -2.730 15
IMN C15 C 12.551 -2.421 16
IMN C16 C 11.991 -0.595 17
IMN C17 C 10.082 2.038 18
IMN C18 C 9.080 3.154 19
IMN N N 9.616 -1.802 20
IMN O O 4.299 0.905 21
IMN O1 O 9.080 -4.344 22
IMN O2 O 9.546 4.580 23
IMN O3 O 7.612 2.845 24
IMN CL Cl 15.953 -4.465 25
#
loop_
_pdbe_chem_comp_bond_depiction.comp_id
_pdbe_chem_comp_bond_depiction.atom_id_1
_pdbe_chem_comp_bond_depiction.atom_id_2
_pdbe_chem_comp_bond_depiction.value_order
_pdbe_chem_comp_bond_depiction.bond_dir
_pdbe_chem_comp_bond_depiction.pdbx_ordinal
IMN C C1 SINGLE NONE 1
IMN C C5 DOUBLE NONE 2
IMN C N SINGLE NONE 3
IMN C1 C2 DOUBLE NONE 4
IMN C1 C7 SINGLE NONE 5
IMN C2 C3 SINGLE NONE 6
IMN C3 C4 DOUBLE NONE 7
IMN C3 O SINGLE NONE 8
IMN C4 C5 SINGLE NONE 9
IMN C6 O SINGLE NONE 10
IMN C7 C8 DOUBLE NONE 11
IMN C7 C17 SINGLE NONE 12
IMN C8 C16 SINGLE NONE 13
IMN C8 N SINGLE NONE 14
IMN C9 C10 SINGLE NONE 15
IMN C9 N SINGLE NONE 16
IMN C9 O1 DOUBLE NONE 17
IMN C10 C11 DOUBLE NONE 18
IMN C10 C15 SINGLE NONE 19
IMN C11 C12 SINGLE NONE 20
IMN C12 C13 DOUBLE NONE 21
IMN C13 C14 SINGLE NONE 22
IMN C13 CL SINGLE NONE 23
IMN C14 C15 DOUBLE NONE 24
IMN C17 C18 SINGLE NONE 25
IMN C18 O2 DOUBLE NONE 26
IMN C18 O3 SINGLE NONE 27
#
loop_
_pdbe_chem_comp_substructure.comp_id
_pdbe_chem_comp_substructure.substructure_name
_pdbe_chem_comp_substructure.id
_pdbe_chem_comp_substructure.substructure_type
_pdbe_chem_comp_substructure.substructure_smiles
_pdbe_chem_comp_substructure.substructure_inchis
_pdbe_chem_comp_substructure.substructure_inchikeys
IMN MurckoScaffold S1 scaffold O=C(c1ccccc1)n1ccc2ccccc21 InChI=1S/C15H11NO/c17-15(13-7-2-1-3-8-13)16-11-10-12-6-4-5-9-14(12)16/h1-11H DIQDUFVJZPNLJQ-UHFFFAOYSA-N
IMN indole F1 fragment 'c1ccc2[nH]ccc2c1' InChI=1S/C8H7N/c1-2-4-8-7(3-1)5-6-9-8/h1-6,9H SIKJAQJRHWYJAI-UHFFFAOYSA-N
IMN phenyl F2 fragment c1ccccc1 InChI=1S/C6H6/c1-2-4-6-5-3-1/h1-6H UHOVQNZJYSORNB-UHFFFAOYSA-N
IMN pyrrole F3 fragment 'c1cc[nH]c1' InChI=1S/C4H5N/c1-2-4-5-3-1/h1-5H KAESVJOAVNADME-UHFFFAOYSA-N
#
loop_
_pdbe_chem_comp_substructure_mapping.comp_id
_pdbe_chem_comp_substructure_mapping.atom_id
_pdbe_chem_comp_substructure_mapping.substructure_id
_pdbe_chem_comp_substructure_mapping.substructure_ordinal
IMN C S1 1
IMN C1 S1 1
IMN C2 S1 1
IMN C3 S1 1
IMN C4 S1 1
IMN C5 S1 1
IMN C7 S1 1
IMN C8 S1 1
IMN C9 S1 1
IMN C10 S1 1
IMN C11 S1 1
IMN C12 S1 1
IMN C13 S1 1
IMN C14 S1 1
IMN C15 S1 1
IMN N S1 1
IMN O1 S1 1
IMN C F1 1
IMN C1 F1 1
IMN C7 F1 1
IMN C8 F1 1
IMN N F1 1
IMN C2 F1 1
IMN C3 F1 1
IMN C4 F1 1
IMN C5 F1 1
IMN C F2 1
IMN C1 F2 1
IMN C2 F2 1
IMN C3 F2 1
IMN C4 F2 1
IMN C5 F2 1
IMN C10 F2 2
IMN C11 F2 2
IMN C12 F2 2
IMN C13 F2 2
IMN C14 F2 2
IMN C15 F2 2
IMN C F3 1
IMN C1 F3 1
IMN C7 F3 1
IMN C8 F3 1
IMN N F3 1
#
_pdbe_chem_comp_rdkit_properties.comp_id IMN
_pdbe_chem_comp_rdkit_properties.exactmw 357.077
_pdbe_chem_comp_rdkit_properties.amw 357.793
_pdbe_chem_comp_rdkit_properties.lipinskiHBA 5
_pdbe_chem_comp_rdkit_properties.lipinskiHBD 1
_pdbe_chem_comp_rdkit_properties.NumRotatableBonds 6
_pdbe_chem_comp_rdkit_properties.NumHBD 1
_pdbe_chem_comp_rdkit_properties.NumHBA 5
_pdbe_chem_comp_rdkit_properties.NumHeavyAtoms 25
_pdbe_chem_comp_rdkit_properties.NumAtoms 41
_pdbe_chem_comp_rdkit_properties.NumHeteroatoms 6
_pdbe_chem_comp_rdkit_properties.NumAmideBonds 0
_pdbe_chem_comp_rdkit_properties.FractionCSP3 0.158
_pdbe_chem_comp_rdkit_properties.NumRings 3
_pdbe_chem_comp_rdkit_properties.NumAromaticRings 3
_pdbe_chem_comp_rdkit_properties.NumAliphaticRings 0
_pdbe_chem_comp_rdkit_properties.NumSaturatedRings 0
_pdbe_chem_comp_rdkit_properties.NumHeterocycles 1
_pdbe_chem_comp_rdkit_properties.NumAromaticHeterocycles 1
_pdbe_chem_comp_rdkit_properties.NumSaturatedHeterocycles 0
_pdbe_chem_comp_rdkit_properties.NumAliphaticHeterocycles 0
_pdbe_chem_comp_rdkit_properties.NumSpiroAtoms 0
_pdbe_chem_comp_rdkit_properties.NumBridgeheadAtoms 0
_pdbe_chem_comp_rdkit_properties.NumAtomStereoCenters 0
_pdbe_chem_comp_rdkit_properties.NumUnspecifiedAtomStereoCenters 0
_pdbe_chem_comp_rdkit_properties.labuteASA 171.514
_pdbe_chem_comp_rdkit_properties.tpsa 68.530
_pdbe_chem_comp_rdkit_properties.CrippenClogP 2.872
_pdbe_chem_comp_rdkit_properties.CrippenMR 92.133
_pdbe_chem_comp_rdkit_properties.chi0v 12.714
_pdbe_chem_comp_rdkit_properties.chi1v 6.758
_pdbe_chem_comp_rdkit_properties.chi2v 3.233
_pdbe_chem_comp_rdkit_properties.chi3v 3.233
_pdbe_chem_comp_rdkit_properties.chi4v 2.161
_pdbe_chem_comp_rdkit_properties.chi0n 27.958
_pdbe_chem_comp_rdkit_properties.chi1n 14.289
_pdbe_chem_comp_rdkit_properties.chi2n 3.044
_pdbe_chem_comp_rdkit_properties.chi3n 3.044
_pdbe_chem_comp_rdkit_properties.chi4n 2.067
_pdbe_chem_comp_rdkit_properties.hallKierAlpha -2.790
_pdbe_chem_comp_rdkit_properties.kappa1 6.180
_pdbe_chem_comp_rdkit_properties.kappa2 6.607
_pdbe_chem_comp_rdkit_properties.kappa3 3.105
_pdbe_chem_comp_rdkit_properties.Phi 1.633
#
loop_
_pdbe_chem_comp_external_mappings.comp_id
_pdbe_chem_comp_external_mappings.source
_pdbe_chem_comp_external_mappings.resource
_pdbe_chem_comp_external_mappings.resource_id
IMN UniChem DrugBank DB00328
IMN UniChem 'Guide to Pharmacology' 1909
IMN UniChem 'KEGG LIGAND' C01926
IMN UniChem ChEBI 49662
IMN UniChem ZINC ZINC000000601283
IMN UniChem eMolecules 522904
IMN UniChem atlas indometacin
IMN UniChem atlas indomethacin
IMN UniChem fdasrs XXE1CET956
IMN UniChem SureChEMBL SCHEMBL9300
IMN UniChem PharmGKB PA449982
IMN UniChem HMDB HMDB0014473
IMN UniChem Selleck Indomethacin(Indocid)
IMN UniChem 'PubChem TPHARMA' 14754602
IMN UniChem NMRShiftDB 20208999
IMN UniChem LINCS LSM-3275
IMN UniChem ACTor 37242-43-6
IMN UniChem ACTor 53-86-1
IMN UniChem Nikkaji J1.368D
IMN UniChem BindingDb 17638
IMN UniChem 'EPA CompTox Dashboard' DTXSID9020740
IMN UniChem DrugCentral 1440
IMN UniChem MetaboLights MTBLC49662
IMN UniChem BRENDA 125887
IMN UniChem BRENDA 127068
IMN UniChem BRENDA 546
IMN UniChem BRENDA 98002
IMN UniChem ChemicalBook CB1750267
IMN UniChem DailyMed INDOMETHACIN
IMN UniChem ClinicalTrials INDOCIN
IMN UniChem ClinicalTrials INDOMETACIN
IMN UniChem ClinicalTrials 'INDOMETACIN SODIUM TRIHYDRATE'
IMN UniChem ClinicalTrials INDOMETHACIN
IMN UniChem ClinicalTrials TIVORBEX
IMN UniChem rxnorm INDOCIN
IMN UniChem rxnorm INDOMETHACIN
IMN UniChem rxnorm 'INDOMETHACIN SODIUM'
IMN UniChem rxnorm TIVORBEX
IMN UniChem MedChemExpress HY-14397
IMN UniChem 'Probes And Drugs' PD002292
IMN UniChem CCDC INDMET
IMN UniChem Mcule MCULE-5636486088
IMN UniChem PubChem 3715
#
loop_
_pdbe_chem_comp_rdkit_conformer.comp_id
_pdbe_chem_comp_rdkit_conformer.atom_id
_pdbe_chem_comp_rdkit_conformer.Cartn_x_rdkit
_pdbe_chem_comp_rdkit_conformer.Cartn_y_rdkit
_pdbe_chem_comp_rdkit_conformer.Cartn_z_rdkit
_pdbe_chem_comp_rdkit_conformer.rdkit_method
_pdbe_chem_comp_rdkit_conformer.rdkit_ordinal
IMN C 1.044 -0.800 -0.487 ETKDGv3 1
IMN C1 1.719 0.437 -0.201 ETKDGv3 2
IMN C2 2.865 0.478 0.483 ETKDGv3 3
IMN C3 3.454 -0.811 0.943 ETKDGv3 4
IMN C4 2.808 -1.978 0.673 ETKDGv3 5
IMN C5 1.521 -1.977 -0.074 ETKDGv3 6
IMN C6 5.354 -1.905 2.153 ETKDGv3 7
IMN C7 0.870 1.497 -0.744 ETKDGv3 8
IMN C8 -0.217 0.913 -1.288 ETKDGv3 9
IMN C9 -1.231 -1.460 -1.416 ETKDGv3 10
IMN C10 -2.589 -1.250 -0.862 ETKDGv3 11
IMN C11 -3.659 -1.855 -1.411 ETKDGv3 12
IMN C12 -5.011 -1.637 -0.855 ETKDGv3 13
IMN C13 -5.180 -0.840 0.208 ETKDGv3 14
IMN C14 -4.011 -0.185 0.830 ETKDGv3 15
IMN C15 -2.785 -0.381 0.329 ETKDGv3 16
IMN C16 -1.353 1.658 -1.929 ETKDGv3 17
IMN C17 1.111 2.972 -0.586 ETKDGv3 18
IMN C18 0.515 3.452 0.698 ETKDGv3 19
IMN N -0.176 -0.523 -1.162 ETKDGv3 20
IMN O 4.667 -0.765 1.648 ETKDGv3 21
IMN O1 -0.984 -2.489 -2.102 ETKDGv3 22
IMN O2 -0.640 3.955 0.710 ETKDGv3 23
IMN O3 1.222 3.302 1.888 ETKDGv3 24
IMN CL -6.782 -0.576 0.869 ETKDGv3 25
IMN H2 3.350 1.418 0.708 ETKDGv3 26
IMN H4 3.207 -2.929 0.998 ETKDGv3 27
IMN H5 0.992 -2.901 -0.265 ETKDGv3 28
IMN H61 4.716 -2.441 2.888 ETKDGv3 29
IMN H62 6.281 -1.573 2.664 ETKDGv3 30
IMN H63 5.631 -2.585 1.320 ETKDGv3 31
IMN H11 -3.552 -2.498 -2.277 ETKDGv3 32
IMN H12 -5.861 -2.123 -1.315 ETKDGv3 33
IMN H14 -4.145 0.449 1.697 ETKDGv3 34
IMN H15 -1.938 0.092 0.808 ETKDGv3 35
IMN H161 -2.017 0.963 -2.482 ETKDGv3 36
IMN H162 -1.945 2.181 -1.150 ETKDGv3 37
IMN H163 -0.964 2.398 -2.659 ETKDGv3 38
IMN H171 2.203 3.173 -0.580 ETKDGv3 39
IMN H172 0.683 3.538 -1.440 ETKDGv3 40
IMN HO3 0.825 3.606 2.769 ETKDGv3 41
#